by Todd Oakland, SVP, GM Biopharma Rx/Dx
Building a Measurable Evidence Engine for Cell, Gene, and RNA Therapies
calendar_today
June 30, 2026
person
Dr. Todd Oakland, SVP & GM, Biopharma RxDx, DNAnexus
domain
dnanexus